Based on these analyses, we can exclude EIF4EBP1 gene amplification or altered EIF4EBP1 promoter methylation as possible mechanisms driving EIF4EBP1 overexpression in malignant gliomas. Here, EIF4EBP1 is linked to malignant glioma.